• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CSL 0.33% $311.12

CSL LIMITED

CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus... CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The Company operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others. More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CSL
CSL - $300 and beyond
2
23/07/24 99 61K
23/07/24 Last post  W534220 Comments Created with Sketch.  99  Views Created with Sketch.  61K 
CSL
News: CSL EU antitrust regulators accept Vifor Pharma's pledge not to disparage rival
22/07/24 0 193
22/07/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  193 
CSL
Only a bit over 4 weeks until results announcement
13/07/24 4 2.5K
Industrials SECTOR NEWS

One Click Group surpasses $3M in revenue YTD with 40% growth

1CG
24 Jul 2024
ONE CLICK GROUP LIMITED
13/07/24 Last post  siren4 Comments Created with Sketch.  4  Views Created with Sketch.  2.5K 
CSL
News: CSL CSL Seqirus Begins Shipping Its Portfolio of Influenza Vaccines for the 2024/25 Flu Season
09/07/24 0 271
09/07/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  271 
CSL
USD adr at one year high
04/07/24 0 553
04/07/24 Last post  W534220 Comments Created with Sketch.  0  Views Created with Sketch.  553 
CSL
Still growth in idelvion
03/07/24 0 431
03/07/24 Last post  W534220 Comments Created with Sketch.  0  Views Created with Sketch.  431 
CSL 03/07/24 0 287
03/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  287 
CSL
News: CSL UPDATE 3-Bird flu concern prompts US to award Moderna $176 million for vaccine development
03/07/24 0 383
03/07/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  383 

See All Discussions arrow Created with Sketch.

Timeline

Notification of cessation of securities - CSL
03 Jul 14:08
 
Notification of cessation of securities - CSL
05 Jun 11:37
 
Notification of cessation of securities - CSL
03 May 12:12
 
Shareholder Information Meetings
23 Apr 09:58
 
CSL Australia Investor Site Tour Presentations
11 Apr 08:25
 
Publication of AEGIS II Trial Data
08 Apr 08:33
 
View More arrow Created with Sketch.
(20min delay)
Last
$311.12
Change
-1.030(0.33%)
Mkt cap ! $151.2B
Open High Low Value Volume
$311.30 $313.55 $310.72 $45.76M 146.5K

Buyers (Bids)

No. Vol. Price($)
10 63 $311.10
 

Sellers (Offers)

Price($) Vol. No.
$311.22 66 6
View Market Depth
Last trade - 13.16pm 24/07/2024 (20 minute delay) ?
Last
$310.85
  Change
-1.030 ( 0.58 %)
Open High Low Volume
$311.23 $313.50 $310.59 15293
Last updated 13.36pm 24/07/2024 ?
CSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.